Aspects of non-specific immunotherapy with BCG in superficial bladder cancer: an overview.
van der Meijden
A P
AP
Department of Urology, University Hospital Nijmegen, The Netherlands.
Debruyne
F M
FM
Steerenberg
P A
PA
de Jong
W H
WH
D000818:Animals; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D004334:Drug Administration Schedule; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine